On April 24, 2026, Jaguar Health, Inc. was granted an extension to remain listed on Nasdaq until May 15, 2026, under the condition they meet the minimum bid price of $1.00 for 10 consecutive days; they also approved a 1-for-35 reverse stock split effective April 30, 2026, to help achieve compliance.